<DOC>
	<DOCNO>NCT00001322</DOCNO>
	<brief_summary>This study evaluate effect estrogen progesterone mood , stress response , brain function healthy woman . The purpose study evaluate low level estrogen progesterone ( occur treatment leuprolide acetate ) compare menstrual cycle level estrogen progesterone ( give individual month hormone add-back ) variety physiologic measure ( brain imaging , stress testing , etc . ) healthy volunteer woman without PMS . This study investigate effect reproductive hormone temporarily stop menstrual cycle leuprolide acetate give , sequence , menstrual cycle hormone progesterone estrogen . Tests ( brain image stress testing , etc . ) perform different hormonal condition ( low estrogen progesterone , progesterone add-back , estrogen add-back ) . The result study compare woman without PMS woman PMS ( see also protocol 90-M-0088 ) . At study entry , participant undergo physical examination . Blood , urine , pregnancy test perform . Cognitive function stress response evaluate study along brain imaging genetic study .</brief_summary>
	<brief_title>The Effects Reproductive Hormones Mood Behavior</brief_title>
	<detailed_description>Evidence suggest gonadal steroid may exert clinically significant effect central nervous system function . For example , menstrual cycle may influence occurrence seizure female epileptic performance certain cognitive test . Central nervous system effect gonadal steroid infer largely change behavior occur association presume change gonadal steroid normal menstrual cycle , administration ovarian hormone , gender-specific context . These inference , definition , indirect associational nature incapable disentangling effect hormones simultaneously present woman reproductive age . This study design address problem compare measure Lupron-induced hypogonadism replacement estrogen progesterone . On basis prior finding group others , ask follow question : 1 ) Is decrease r-CBF observed prefrontal cortex hypogonadal state confirm individual woman use new image technique ; 2 ) Will variation genotype ( e.g. , COMT val/met , BDNF val/met ) confer differential sensitivity ovarian steroid brain circuitry 3 ) Are menstrual cycle phase-related change reward system previously observe related estradiol progesterone action within brain ( 1 ) . Additionally , protocol serve control study protocol # 90-M-0088 .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>INCLUSION CRITERIA : Volunteers participate study woman meet follow criterion : Between age 18 50 year , Not pregnant , In good medical health , Medication free , No history menstrualrelated mood behavioral disturbance . Additionally , recruit subsample 20 asymptomatic woman meet inclusion exclusion criterion protocol except history past major depressive episode . Finally , third sample 10 woman meet inclusion exclusion criterion list protocol recruited establish dose range transdermal estrogen gel relate protocol ( i.e. , 90M0088 05M0059 ) . EXCLUSION CRITERIA : The following condition constitute contraindication treatment hormonal therapy preclude subject 's participation protocol : Current Axis I psychiatric diagnosis ( exception woman past major depression study protocol ) ; History consistent endometriosis ; Diagnosis illdefined , obscure pelvic lesion , particularly undiagnosed ovarian enlargement ; Hepatic disease manifest abnormal liver function test ; History mammary carcinoma ; History pulmonary embolism phlebothrombosis ; Undiagnosed vaginal bleeding ; Porphyria ; Diabetes mellitus ; History malignant melanoma ; Cholecystitis pancreatitis ; Cardiovascular renal disease ; Pregnancy ; Any woman meeting Stages Reproductive Aging Workshop Criteria ( STRAW ) perimenopause ( 129 ) . Specifically , exclude woman elevate plasma FSH level ( great equal 14 IU/L ) menstrual cycle variability &gt; 7 day different normal cycle length . NIMH employees/staff immediate family member exclude study per NIMH policy . Subjects take birth control pill exclude study . Subjects take diuretic , prostaglandin inhibitor , pyridoxine ( putative treatment MRMD ) similarly exclude study , patient take psychotropic agent ( e.g. , lithium carbonate , tricyclic antidepressant ) . All subject require use nonhormonal form birth control ( e.g. , barrier method ) avoid pregnancy study . Participants active condition place increase risk osteoporosis exclude protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 24, 2017</verification_date>
	<keyword>Gonadal Steroids</keyword>
	<keyword>Mood</keyword>
	<keyword>Menstrual Cycle</keyword>
	<keyword>Neuropsychological Testing</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Central Nervous System Function</keyword>
	<keyword>Estradiol</keyword>
	<keyword>GnRH Agonist</keyword>
</DOC>